Showing 551-560 of 1330 results for "".
Immune-Mediated Cerebellar Ataxias
https://practicalneurology.com/diseases-diagnoses/movement-disorders/immune-mediated-cerebellar-ataxias/31708/Cerebellar ataxia may be a prominent feature in autoimmune encephalitis and paraneoplastic syndromes.NeuroAdvocacy: Why Lobbying Matters
https://practicalneurology.com/columns/practice-management/neuroadvocacy-why-lobbying-matters/30328/Advocating for patients and the specialty is a powerful way for physicians to make their voices heard.Updates in Diagnostic Testing in Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/updates-in-diagnostic-testing-in-parkinson-disease/32164/A review of diagnostic tests for Parkinson disease, including DAT-SPECT, α-synuclein skin biopsy and CSF studies, and genetic testing, offering guidance on their appropriate use and interpretation.Brain Imaging in Differential Diagnosis of Dementia
https://practicalneurology.com/diseases-diagnoses/imaging-testing/brain-imaging-in-differential-diagnosis-of-dementia/31533/Imaging biomarkers hold the promise of earlier diagnosis that may lead to more effective treatment.Posttraumatic Headache Associated with Mild Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/posttraumatic-headache-associated-with-mild-traumatic-brain-injury/31993/Diagnosis and treatment of posttraumatic headache associated with mTBI, including onset, headache characteristics, and persistenceInflammatory Myopathies
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/inflammatory-myopathies/31812/Clinicopathologic classfication can aid understanding and guide treatment.Expert Opinion: Male Opioid-Induced Hypogonadism in the Management of Chronic Pain
https://practicalneurology.com/diseases-diagnoses/headache-pain/expert-opinion-male-opioid-induced-hypogonadism-in-the-management-of-chronic-pain/30753/Patients on long-term opioid therapy should be actively monitored for signs and symptoms consistent with hypogonadism.PFO Closure for Cryptogenic Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/pfo-closure-for-cryptogenic-stroke/30294/Data from three randomized clinical trials offer promising results for the use of patent foramen ovale closure in the treatment of cryptogenic stroke.POINT-COUNTERPOINT: Natalizumab Extended-Interval Dosing
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/point-counterpoint-natalizumab-extended-interval-dosing/30124/Optimism vs caution for using extended-interval dosing to prevent progressive multifocal leukoencephalopathy.Movement Disorders Moment: Environmental and Biologic Risk and Protective Factors Associated with Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-momentbrenvironmental-and-biologic-risk-and-protective-factors-associated-with-parkinson-disease/32120/This review provides a concise summary of the evidence for environmental and biologic risk and protective factors for Parkinson disease.